Experimental coronavirus retinopathy (ECOR): Retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection

Journal of Neuroimmunology

Volumn 193, Issue 1-2, 2008, Pages 28-37

  Detrick, Barbara ^a,b   Lee, Maria Teresa ^a,b   Chin, Marian S ^a,b   Hooper, Laura C ^a,b   Chan, Chi Chao ^a,b   Hooks, John J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

Autoimmunity; Chemokines; Coronavirus; Interferon; Retinal degeneration

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CORONAVIRUS; CYTOKINE RELEASE; GENE EXPRESSION; IMMUNE RESPONSE; INNATE IMMUNITY; INTERFERON PRODUCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA DEGENERATION; RETINOPATHY; VIRUS INFECTION;

ANIMALS; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CORONAVIRUS INFECTIONS; IMMUNITY, NATURAL; INTERFERONS; MALE; MICE; MICE, INBRED BALB C; MURINE HEPATITIS VIRUS; RETINAL DEGENERATION; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 37749051917     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.032     Document Type: Article

References (44)

1. Bergmann C.C., Lane T.E., and Stohlman S.A. Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev., Microbiol. 4 (2006) 121-132
2. Blenman K.R., Duan B., Xu Z., Wan S., Atkinson M.A., Flotte T.R., Croker B.P., and Morel L. IL-10 regulation of lupus in the NZM2410 murine model. Lab. Invest. 86 (2006) 1136-1148
3. Carr D.J., Chodosh J., Ash J., and Lane T.E. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J. Virol. 77 (2003) 10037-10046
4. Chen J., and Subbarao K. The immunobiology of SARS. Annu. Rev. Immunol. 25 (2007) 443-472
5. Christen U., McGavern D.B., Luster A.D., von Herrath M.G., and Oldstone M.B. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 171 (2003) 6838-6845
6. Coelho A.L., Hogaboam C.M., and Kunkel S.L. Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev. 16 (2005) 553-560
7. Dufour J.H., Dziejman M., Liu M.T., Leung J.H., Lane T.E., and Luster A.D. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol. 168 7 (2002) 3195-3204 (Apr 1)
8. Harasawa H., Yamada Y., Hieshima K., Jin Z., Nakayama T., Yoshie O., Shimizu K., Hasegawa H., Hayashi T., Imaizumi Y., Ikeda S., Soda H., Soda H., Atogami S., Takasaki Y., Tsukasaki K., Tomonaga M., Murata K., Sugahara K., Tsuruda K., and Kamihira S. Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma. Leuk. Lymphoma 47 (2006) 2163-2173
9. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282 (2007) 15325-15329
10. Holmes K. Coronaviruses. In: Knipe D., and Howley P. (Eds). Fields Virology vol. 1 (2001), Lipincott Williams & Wilkins, Philadelphia 1187-1203
11. Hooks J.J., Chan C.C., and Detrick B. Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. Invest. Ophthalmol. Vis. Sci. 29 (1988) 1444-1451
12. Hooks J.J., Percopo C., Wang Y., and Detrick B. Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy. J. Immunol. 151 (1993) 3381-3389
13. Hooks J.J., Tso M.O., and Detrick B. Retinopathies associated with antiretinal antibodies. Clin. Diagn. Lab. Immunol. 8 (2001) 853-858
14. Hooks J.J., Wang Y., and Detrick B. The critical role of IFN-gamma in experimental coronavirus retinopathy. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3402-3408
15. Hooper L.C., Chin M.S., Detrick B., and Hooks J.J. Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-alpha, soluble TNFR2 and altered TNF-alpha signaling. J. Neuroimmunol. 166 (2005) 65-74
16. Huang K.J., Su I.J., Theron M., Wu Y.C., Lai S.K., Liu C.C., and Lei H.Y. An interferon-gamma-related cytokine storm in SARS patients. J. Med. Virol. 75 (2005) 185-194
17. Jiang Y., Xu J., Zhou C., Wu Z., Zhong S., Liu J., Luo W., Chen T., Qin Q., and Deng P. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 171 (2005) 850-857
18. Khan I.A., MacLean J.A., Lee F.S., Casciotti L., DeHaan E., Schwartzman J.D., and Luster A.D. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12 (2000) 483-494
19. Klein R.S., Lin E., Zhang B., Luster A.D., Tollett J., Samuel M.A., Engle M., and Diamond M.S. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79 (2005) 11457-11466
20. Komurasaki Y., Nagineni C.N., Wang Y., and Hooks J.J. Virus RNA persists within the retina in coronavirus-induced retinopathy. Virology 222 (1996) 446-450
21. Krathwohl M.D., and Anderson J.L. Chemokine CXCL10 (IP-10) is sufficient to trigger an immune response to injected antigens in a mouse model. Vaccine 24 (2006) 2987-2993
22. Kumar M.V., Nagineni C.N., Chin M.S., Hooks J.J., and Detrick B. Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. J. Neuroimmunol. 153 (2004) 7-15
23. Lang K.S., Georgiev P., Recher M., Navarini A.A., Bergthaler A., Heikenwalder M., Harris N.L., Junt T., Odermatt B., Clavien P.A., Pircher H., Akira S., Hengartner H., and Zinkernagel R.M. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J. Clin. Invest. 116 (2006) 2456-2463
24. Liu M.T., and Lane T.E. Chemokine expression and viral infection of the central nervous system: regulation of host defense and neuropathology. Immunol. Res. 24 2 (2001) 111-119
25. Lo A.W., Tang N.L., and To K.F. How the SARS coronavirus causes disease: host or organism?. J. Pathol. 208 (2006) 142-151
26. Medoff B., and Luster A. Chemokines and chemokine receptor analysis. In: Detrick B., Hamilton R., and Folds J. (Eds). Manual of Molecular and Clinical Laboratory Immunology vol. 7 (2006), ASM Press, Washington, DC 371-384
27. Mihm S., Schweyer S., and Ramadori G. Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J. Med. Virol. 70 (2003) 562-570
28. Morimoto J., Yoneyama H., Shimada A., Shigihara T., Yamada S., Oikawa Y., Matsushima K., Saruta T., and Narumi S. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis. J. Immunol. 173 (2004) 7017-7024
29. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., and Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 264 (1994) 1918-1921
30. Parra B., Hinton D.R., Marten N.W., Bergmann C.C., Lin M.T., Yang C.S., and Stohlman S.A. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162 (1999) 1641-1647
31. Pestka S., Krause C.D., and Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202 (2004) 8-32
32. Robbins S.G., Hamel C.P., Detrick B., and Hooks J.J. Murine coronavirus induces an acute and long-lasting disease of the retina. Lab. Invest. 62 (1990) 417-426
33. Salomon I., Netzer N., Wildbaum G., Schif-Zuck S., Maor G., and Karin N. Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis. J. Immunol. 169 (2002) 2685-2693
34. Tang N.L., Chan P.K., Wong C.K., To K.F., Wu A.K., Sung Y.M., Hui D.S., Sung J.J., and Lam C.W. Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin. Chem. 51 (2005) 2333-2340
35. Tran E.H., Azuma Y.T., Chen M., Weston C., Davis R.J., and Flavell R.A. Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13451-13456
36. Trifilo M.J., Montalto-Morrison C., Stiles L.N., Hurst K.R., Hardison J.L., Manning J.E., Masters P.S., and Lane T.E. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 78 (2004) 585-594
37. Ure D.R., Lane T.E., Liu M.T., and Rodriguez M. Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection. Int. Immunol. 17 (2005) 569-579
38. Vinores S.A., Wang Y., Vinores M.A., Derevjanik N.L., Shi A., Klein D.A., Detrick B., and Hooks J.J. Blood-retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains. J. Neuroimmunol. 119 (2001) 175-182
39. Wallace G.R., John Curnow S., Wloka K., Salmon M., and Murray P.I. The role of chemokines and their receptors in ocular disease. Prog. Retin. Eye Res. 23 (2004) 435-448
40. Wang Y., Detrick B., and Hooks J.J. Coronavirus (JHM) replication within the retina: analysis of cell tropism in mouse retinal cell cultures. Virology 193 (1993) 124-137
41. Wang Y., Burnier M., Detrick B., and Hooks J.J. Genetic predisposition to coronavirus-induced retinal disease. Invest. Ophthalmol. Vis. Sci. 37 (1996) 250-254
42. Wang J.P., Kurt-Jones E.A., and Finberg R.W. Innate immunity to respiratory viruses. Cell. Microbiol. 9 (2007) 1641-1646
43. Wong C.K., Lam C.W., Wu A.K., Ip W.K., Lee N.L., Chan I.H., Lit L.C., Hui D.S., Chan M.H., Chung S.S., and Sung J.J. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 136 (2004) 95-103
44. Yang Y.H., Huang Y.H., Chuang Y.H., Peng C.M., Wang L.C., Lin Y.T., and Chiang B.L. Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection. J. Med. Virol. 77 (2005) 1-7